The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Stelzer Laurie since 2015.
This trader's CIK number is 1644348.
At the time of last reporting, Stelzer Laurie was the Chief Financial Officer of Mirati Therapeutics, Inc.. (stock ticker symbol MRTX).
Also see all insider trading activities at Mirati Therapeutics, Inc..
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2021 | ARNA | 0 | $0 | 0 | $0 | 12,600 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2023 | MRTX | 0 | $0 | 4,647 | $172,217 | 0 | $0 |
Insider Buying | Insider Sales | Option Exercises | |||||
---|---|---|---|---|---|---|---|
Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
2020 | HALO | 0 | $0 | 0 | $0 | 53,582 | $0 |
2019 | HALO | 0 | $0 | 0 | $0 | 49,195 | $0 |
2018 | HALO | 0 | $0 | 0 | $0 | 41,387 | $0 |
2017 | HALO | 0 | $0 | 0 | $0 | 29,995 | $0 |
2016 | HALO | 0 | $0 | 0 | $0 | 6,875 | $0 |
2015 | HALO | 10,000 | $172,380 | 0 | $0 | 0 | $0 |
1. Arena Pharmaceuticals Inc (ARNA)
2. Mirati Therapeutics, Inc. (MRTX)
3. Halozyme Therapeutics, Inc. (HALO)
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-03-16 | ARNA | Option Ex | 12,600 | .00 | 0 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2023-06-02 | MRTX | Sale | 4,647 | 37.06 | 172,217 |
Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2020-02-22 | HALO | Option Ex | 11,392 | .00 | 0 |
2020-02-14 | HALO | Option Ex | 7,809 | .00 | 0 |
2020-02-12 | HALO | Option Ex | 11,262 | .00 | 0 |
2020-02-03 | HALO | Option Ex | 23,119 | .00 | 0 |
2019-06-15 | HALO | Option Ex | 6,875 | .00 | 0 |
2019-02-22 | HALO | Option Ex | 11,392 | .00 | 0 |
2019-02-14 | HALO | Option Ex | 7,809 | .00 | 0 |
2019-02-03 | HALO | Option Ex | 23,119 | .00 | 0 |
2018-06-15 | HALO | Option Ex | 6,875 | .00 | 0 |
2018-02-22 | HALO | Option Ex | 11,392 | .00 | 0 |
2018-02-03 | HALO | Option Ex | 23,120 | .00 | 0 |
2017-06-15 | HALO | Option Ex | 6,875 | .00 | 0 |
2017-02-03 | HALO | Option Ex | 23,120 | .00 | 0 |
2016-06-15 | HALO | Option Ex | 6,875 | .00 | 0 |
2015-08-20 | HALO | Buy | 10,000 | 17.24 | 172,380 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Stelzer Laurie (Chief Financial Officer of Mirati Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.